Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–5 of 5 results
Advanced filters: Author: Martin Rudwaleit Clear advanced filters
  • Owing to the long diagnostic delay in spondyloarthritis (SpA), the effective identification of those individuals who are likely to have axial SpA among patients with chronic back pain in primary care and their subsequent referral to a rheumatologist for establishing a correct diagnosis is worth pursuing. In this article, the authors discuss potential referral criteria and present clinical studies in which their effectiveness in identifying patients with SpA has been examined.

    • Martin Rudwaleit
    • Joachim Sieper
    Reviews
    Nature Reviews Rheumatology
    Volume: 8, P: 262-268
  • In the second of two Perspectives articles regarding the use of MRI to detect inflammatory lesions in early preclinical axial spondyloarthritis, van der Heijde et al. defend the inclusion of MRI sacroiliitis in the 2009 ASAS classification criteria and acknowledge the importance of expert opinion in the diagnosis of this disease.

    • Désirée van der Heijde
    • Martin Rudwaleit
    • Jochen Sieper
    Reviews
    Nature Reviews Rheumatology
    Volume: 6, P: 670-672
  • Diagnostic algorithms for axial spondyloarthritis (SpA), and classification criteria for use in clinical trials, are being developed and refined. But can axial SpA be ruled out in young patients with only one clinical feature of SpA prior to imaging studies and HLA-B27 testing?

    • Martin Rudwaleit
    News & Views
    Nature Reviews Rheumatology
    Volume: 12, P: 378-380
  • In light of the impressive efficacy of tumor necrosis factor blockers in the treatment of ankylosing spondylitis, particularly in patients with short disease duration, defining outcome parameters to monitor the structural damage of the disease has become more pertinent. In this Viewpoint the authors explore the relevance of osteoproliferation amongst other outcome parameters.

    • Heiner Appel
    • Martin Rudwaleit
    • Joachim Sieper
    Reviews
    Nature Clinical Practice Rheumatology
    Volume: 4, P: 578-579